John Connaughton - IQVIA Holdings Independent Director
| IQV Stock | USD 219.23 1.26 0.57% |
Director
Mr. John P. Connaughton is Independent Director of the Company. He has served as a director since January 2008. Mr. Connaughton is a CoManaging Partner and Managing Director of Bain Capital, which he joined in 1989. Prior to joining Bain Capital, Mr. Connaughton was a consultant at Bain Company, Inc., where he worked in the healthcare, consumer products and business services industries. Mr. Connaughton also serves on the boards of directors of iHeartMedia, Inc. and The Boston Celtics. Mr. Connaughton was formerly a director of Beacon Health Options, Inc., Grupo Notre Dame Intermedica, SunGard Data Systems Inc., Warner Music Group Corporationration, Warner Chilcott plc, HCA Holdings, Inc., CRC Health Corporationrationration, BIO Products Laboratory, and Air Medical Group Holdings, Inc. He also volunteers for a variety of charitable organizations, serving as a member of The Berklee College of Music Board of Trustees and the University of Virginia McIntire Foundation Board of Trustees since 2008.
| Age | 54 |
| Tenure | 16 years |
| Professional Marks | MBA |
| Address | 2400 Ellis Road, Durham, NC, United States, 27703 |
| Phone | 919 998 2000 |
| Web | https://www.iqvia.com |
John Connaughton Latest Insider Activity
Tracking and analyzing the buying and selling activities of John Connaughton against IQVIA Holdings stock is an integral part of due diligence when investing in IQVIA Holdings. John Connaughton insider activity provides valuable insight into whether IQVIA Holdings is net buyers or sellers over its current business cycle. Note, IQVIA Holdings insiders must abide by specific rules, including filing SEC forms every time they buy or sell IQVIA Holdings'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
John Connaughton over a month ago Acquisition by John Connaughton of 1047 shares of IQVIA Holdings subject to Rule 16b-3 |
IQVIA Holdings Management Efficiency
The company has Return on Asset of 0.0503 % which means that on every $100 spent on assets, it made $0.0503 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2211 %, implying that it generated $0.2211 on every 100 dollars invested. IQVIA Holdings' management efficiency ratios could be used to measure how well IQVIA Holdings manages its routine affairs as well as how well it operates its assets and liabilities. At this time, IQVIA Holdings' Return On Capital Employed is fairly stable compared to the past year. Return On Assets is likely to climb to 0.06 in 2024, whereas Return On Tangible Assets are likely to drop 0.1 in 2024. At this time, IQVIA Holdings' Other Current Assets are fairly stable compared to the past year. Debt To Assets is likely to climb to 0.65 in 2024, whereas Non Current Assets Total are likely to drop slightly above 13.7 B in 2024.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Dion Weisler | Thermo Fisher Scientific | 53 | |
| Elias Zerhouni | Danaher | 69 | |
| Tadataka Yamada | Agilent Technologies | 74 | |
| Hans Bishop | Agilent Technologies | 56 | |
| Martin Mackay | Charles River Laboratories | 65 | |
| Nelson Chai | Thermo Fisher Scientific | 55 | |
| Walter Lohr | Danaher | 77 | |
| Lars Sorensen | Thermo Fisher Scientific | 67 | |
| James Mullen | Thermo Fisher Scientific | 62 | |
| Heidi Kunz | Agilent Technologies | 66 | |
| Judy Lewent | Thermo Fisher Scientific | 71 | |
| Richard Wallman | Charles River Laboratories | 69 | |
| Nancy Andrews | Charles River Laboratories | 63 | |
| Teri ListStoll | Danaher | 58 | |
| George Scangos | Agilent Technologies | 72 | |
| Virginia Wilson | Charles River Laboratories | 66 | |
| Deborah Kochevar | Charles River Laboratories | 64 | |
| Scott Sperling | Thermo Fisher Scientific | 63 | |
| Francis deSouza | Illumina | 53 | |
| Alan Spoon | Danaher | 69 | |
| R Keith | Thermo Fisher Scientific | 52 | |
Management Performance
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.0503 |
IQVIA Holdings Leadership Team
Elected by the shareholders, the IQVIA Holdings' board of directors comprises two types of representatives: IQVIA Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IQVIA. The board's role is to monitor IQVIA Holdings' management team and ensure that shareholders' interests are well served. IQVIA Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IQVIA Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ari Bousbib, Chairman of the Board, President, Chief Executive Officer | ||
| Nicholas Childs, Senior Treasury | ||
| John Danhakl, Independent Director | ||
| Trudy Stein, Chief VP | ||
| Andrea Spannheimer, Global Research | ||
| Richard III, President Solutions | ||
| Walter Staub, President - Research and Development Solutions | ||
| Michael McDonnell, Chief Financial Officer, Executive Vice President | ||
| Andrew Markwick, VP Relations | ||
| Carol Burt, Independent Director | ||
| Jon Resnick, President Canada | ||
| John Leonard, Lead Independent Director | ||
| Keriann Cherofsky, Corporate VP | ||
| Gregg Dearhammer, Safety Sciences | ||
| Cynthia Verst, President Innovation | ||
| Jeffrey MD, Global VP | ||
| James Fasano, Independent Director | ||
| Ronald Bruehlman, Interim Chief Financial Officer, Executive Vice President | ||
| Jeffrey Spaeder, Global VP | ||
| John Connaughton, Independent Director | ||
| Colleen Goggins, Independent Director | ||
| Nilton Paletta, President America | ||
| Todd Sisitsky, Independent Director | ||
| Eric Sherbet, Executive Vice President General Counsel, Secretary | ||
| Costa Panagos, President - Research & Development Solutions | ||
| Lucas Glass, Global Excellence | ||
| Rob Kotchie, President Solutions | ||
| Wendy Stewart, President Operations | ||
| Kerri Joseph, SVP Treasury | ||
| Jim Berkshire, Executive Operations | ||
| Alistair Grenfell, Middle Europe | ||
| Karl Guenault, Senior Officer | ||
| Ronald Rittenmeyer, Independent Director | ||
| Brian Mi, President Pacific | ||
| Kevin Knightly, President - Information and Technology Solutions |
IQVIA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is IQVIA Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.0503 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 52.26 B | ||||
| Shares Outstanding | 182.2 M | ||||
| Shares Owned By Insiders | 0.92 % | ||||
| Shares Owned By Institutions | 90.42 % | ||||
| Number Of Shares Shorted | 3.04 M | ||||
| Price To Earning | 103.68 X |
Pair Trading with IQVIA Holdings
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if IQVIA Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IQVIA Holdings will appreciate offsetting losses from the drop in the long position's value.Moving together with IQVIA Stock
Moving against IQVIA Stock
| 0.83 | AZN | AstraZeneca PLC ADR | PairCorr |
| 0.69 | DSGN | Design Therapeutics | PairCorr |
| 0.59 | PTN | Palatin Technologies Fiscal Year End 26th of September 2024 | PairCorr |
| 0.58 | HCM | HUTCHMED DRC | PairCorr |
| 0.54 | VALN | Valneva SE ADR | PairCorr |
The ability to find closely correlated positions to IQVIA Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace IQVIA Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back IQVIA Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling IQVIA Holdings to buy it.
The correlation of IQVIA Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as IQVIA Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if IQVIA Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for IQVIA Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for IQVIA Stock Analysis
When running IQVIA Holdings' price analysis, check to measure IQVIA Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IQVIA Holdings is operating at the current time. Most of IQVIA Holdings' value examination focuses on studying past and present price action to predict the probability of IQVIA Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IQVIA Holdings' price. Additionally, you may evaluate how the addition of IQVIA Holdings to your portfolios can decrease your overall portfolio volatility.